Terminally ill woman followed through with her decision to end her life

the ONA take:

A 29-year-old woman with a likely stage 4 glioblastoma ended her life by taking a fatal dose of barbiturates, prescribed by her doctors.

The controversial case drew international attention when the woman, Brittany Maynard, announced her intent to end her own life in an online video campaign launched on October 6. Maynard’s story, however, began months earlier. She was first told of her diagnosis in January. Maynard underwent surgery to remove as much of the tumor as possible, but the tumor grew back 2 months later and was larger. Her prognosis was grim.

She researched her treatment options, discussed them with her doctors, and made her decision to forgo chemotherapy and radiation and to end her own life. Maynard and her family moved to Oregon because the state’s Death with Dignity Act allows physicians to prescribe life-ending medication to certain terminally ill patients.

Although Maynard chose November 1 as the date she would end her life, she was open to pushing it back or forward depending on her condition and symptoms. In this account of her illness, Maynard explained how she made her decision and lived out the rest of her life, and the legacy her decision would leave. Currently, three states have Death with Dignity laws: Oregon, Washington, and Vermont.

Patient environment is important
Brittany Maynard ended her life by taking a fatal dose of barbiturates.

Brittany Maynard, who became the public face of the controversial right-to-die movement over the last few weeks, ended her own life Saturday at her home in Portland, Oregon. She was 29.

"Goodbye to all my dear friends and family that I love. Today is the day I have chosen to pass away with dignity in the face of my terminal illness, this terrible brain cancer that has taken so much from me … but would have taken so much more," she wrote on Facebook.

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs